Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting

mia.burns RESEARCH TRIANGLE PARK, N.C., Oct. 4, 2013 /CNW/ – Grifols Inc., a leading manufacturer of life-saving plasma protein therapies, today announced the launch of the SPIRIT ...

4th annual report: Pharma employment snapshot

Read more Pharmalive – The Pulse of the Pharmaceutical Industry

Training Execs from Top Medical Device and Diagnostic Companies to Host Annual Medical Sales Trainer Summit

barbara.lempert Event topics will focus on ACA, Learning Metrics and ROI, Patient and Product Outcomes, e-Learning, mHealth, Global Sales Education, and the role of Sales Trainers ROANOKE, ...

Isotechnika Shareholders Approve Merger With Aurinia at Annual and Special Meeting

mia.burns EDMONTON, Alberta, Aug. 16, 2013 (GLOBE NEWSWIRE) — Isotechnika Pharma Inc. (TSX:ISA) (“Isotechnika” or the “Company”) announced that at its ...

23rd annual report: Top 100 medicine highlights

chris.truelove By Andrew Humphreys andrew.humphreys@ubm.com 2012 marked the first year since 2000 that Lipitor was not the top-selling prescription medicine on a global scale. The ...

Analysis reflects a near doubling of annual new drug approvals for neglected diseases

mia.burns By Mia Burns The Tufts Center for the Study of Drug Development has released new analysis indicating that the annual number of new drug approvals globally to treat neglected ...

Regeneron Announces First Recipients of Annual Regeneron Prize for Creative Innovation

barbara.lempert New National Prize Recognizes Talented Early-Career Scientists Poised to Make Important Contributions to Scientific Discovery TARRYTOWN, N.Y., June 27, 2013 /PRNewswire/ ...

Proxy challenger scoffs at Vivus as annual meeting nears

Tracy Staton Vivus' annual meeting is fast approaching, so it's no surprise that First Manhattan has issued another missive to its fellow shareholders. In the sarcastic, scoffing ...

22nd Annual Report: Top 100 Biotechnology Companies

chris.truelove Biotech industry growth is bolstered by increased R&D spending, an upswing of approved first-in-class medicines, elevated Wall Street valuations, and continued forging ...

Flamel Tech Rises to Annual High on Drug Approval

barbara.lempert NEW YORK (AP) — Flamel Technologies SA said Monday that the Food and Drug Administration approved its drug Bloxiverz, which is designed to reverse the effects ...

iCo Therapeutics Announces Director Election Results from its Annual General Meeting of Shareholders

barbara.lempert VANCOUVER, May 24, 2013 /CNW/ – iCo Therapeutics Inc. (“iCo” or “the Company”) (TSX-V: ICO) announced today that that all nominees listed ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS